Generic drug maker Barr Pharmaceuticals Inc. has triggered a patent infringement lawsuit from Celgene Corp., a New Jersey drug maker that says Barr trampled the intellectual property rights for its leading cancer treatment.
In another victory for Merck & Co., a woman who blamed her husband’s death on the painkiller Vioxx dropped her lawsuit against the pharmaceutical company on Monday, five weeks before it was scheduled to go to trial.
When an energy transmission developer had the ambitious idea to link energy hungry cities with producers miles away using underwater cable lines, it turned to one energy practice to help it with its project: Skadden, Arps, Slate, Meagher & Flom LLP.
The U.S. Court of Appeals for the Federal Circuit upheld a lower court ruling Friday that allowed a subsidiary of India’s Sun Pharmaceuticals to market a generic version of Johnson & Johnson’s pain medication Ultracet.
Jurors have failed to reach a unanimous decision in two product liability cases alleging that Merck & Co.’s controversial painkiller Vioxx induced heart attacks.
Pfizer Inc. has filed a patent infringement suit against a subsidiary of Israeli generics maker Teva Pharmaceuticals Industries Ltd. in an attempt to protect the market for the world’s leading prescription bladder control drug Detrol.
The murky intersection of patent term extensions and terminal disclaimers could soon be cleared up by a federal appeals court ruling in an otherwise standard patent infringement suit from Merck & Co. Inc., lawyers say.
Israeli generic drug maker Teva Pharmaceuticals Industries Ltd. has filed a patent infringement lawsuit against Andrx Corp. and other rivals, accusing the group of jumping the gun in their plans to launch generic versions of Pfizer Inc.’s blockbuster depression drug Zoloft.
In a favorable 2-1 ruling for the world’s largest retailer, an appeals court has found that Maryland’s contentious “Wal-Mart law,” which would have forced the company to provide health insurance to its employees, is a violation of federal law.
Threatening to usher in a new wave of Vioxx lawsuits, a New Jersey appeals court has revived a proposed class action that seeks to force the pharmaceutical giant to cover medical-surveillance tests for individuals who took the controversial painkiller but have yet to suffer from any health problems.
A U.S. Bankruptcy Court judge has granted foundering passenger and freight company Sea Containers Ltd. an extention to file a reorganization plan.
When Philadelphia-headquartered Duane Morris started a health law practice in 1977, most hospitals were represented by lawyers who served on their boards.
The boss of three former Merrill Lynch brokers embroiled in the 2003 market-timing scandal has been fined by the New York Stock Exchange for failing to supervise the trio.
Two companies that offer online debt collection services have squared off in a New Jersey court over patents covering computerized dispute resolution systems.
The federal circuit has ruled against the majority of appeals made by a photo company owner who claimed he did not violate patents held by Fuji Photo Film Co., but remanded the case back to the U.S. International Trade Commission to adjust civil penalties based on a favorable ruling on one appeal.
On the two-year anniversary of India’s revamped patent laws, generic drug makers in the country are shoring up their legal departments, boosting research and development, and setting their sights beyond national borders in a bid to beef up sales in the most lucrative pharmaceutical markets.
A handful of Wall Street investment banks should be held accountable for their role in the Enron Corp. accounting fraud, according to a motion filed by the attorneys general of 30 states.
Merck & Co. Inc. and its lawyers have been chastised by a judge in the drug maker's dispute with the New England Journal of Medicine in the pending mass-tort litigation over the company’s former blockbuster drug Vioxx.
The U.S. unit of French drug firm Sanofi-Aventis has become the latest target in a series of lawsuits brought by employees accusing pharmaceutical giants of violating state and federal overtime laws.
Swiss pharmaceutical giant Novartis International AG has filed another patent suit against Par Pharmaceuticals, seeking to protect the market for billion-dollar hypertension treatment Lotrel.